Wealthfront Advisers LLC increased its stake in Medtronic PLC (NYSE:MDT) by 14.7% in the third quarter, holding 86,543 shares valued at over $8.24 million. Other institutional investors like Vanguard and Geode also boosted their positions, with institutional ownership now at 82.06%. Analysts maintain a “Moderate Buy” rating for Medtronic, with an average price target of $111.21, following recent upgrades from Barclays and Daiwa, and the company reported strong quarterly earnings, beating expectations.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Medtronic PLC $MDT Shares Bought by Wealthfront Advisers LLC
Wealthfront Advisers LLC increased its stake in Medtronic PLC (NYSE:MDT) by 14.7% in the third quarter, holding 86,543 shares valued at over $8.24 million. Other institutional investors like Vanguard and Geode also boosted their positions, with institutional ownership now at 82.06%. Analysts maintain a “Moderate Buy” rating for Medtronic, with an average price target of $111.21, following recent upgrades from Barclays and Daiwa, and the company reported strong quarterly earnings, beating expectations.